Effects of chronic sildenafil in patients with Eisenmenger syndrome versus idiopathic pulmonary arterial hypertension
- 3 September 2007
- journal article
- clinical trial
- Published by Elsevier BV in International Journal of Cardiology
- Vol. 120 (3), 301-305
- https://doi.org/10.1016/j.ijcard.2006.10.018
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Sildenafil Citrate Therapy for Pulmonary Arterial HypertensionThe New England Journal of Medicine, 2005
- Endothelin receptor antagonists in pulmonary arterial hypertensionJournal of the American College of Cardiology, 2004
- Diagnosis and differential assessment of pulmonary arterial hypertensionJournal of the American College of Cardiology, 2004
- Sildenafil Use in Patients With the Eisenmenger SyndromeCirculation, 2004
- Clinical efficacy of sildenafil in primary pulmonary hypertension: A randomized, placebo-controlled, double-blind, crossover studyJournal of the American College of Cardiology, 2004
- Poor prognosis and related factors in adults with Eisenmenger syndrome.American Heart Journal, 2002
- Bosentan Therapy for Pulmonary Arterial HypertensionThe New England Journal of Medicine, 2002
- Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled studyThe Lancet, 2001
- The Eisenmenger Syndrome: IBMJ, 1958